Evaluating the Merits of Merit Medical Systems
January 5, 2023
Trending News ☀️
In addition, it provides materials management and inventory services for hospitals, clinics and other health care providers. With a market cap of over $4 billion and a presence in more than 70 countries, Merit Medical Systems ($NASDAQ:MMSI) Inc. is an attractive option for investors looking for long-term returns. Moreover, Merit Medical Systems Inc. has a diverse customer base and product portfolio. The company has established relationships with many major medical device manufacturers, as well as a robust research and development department that continues to develop innovative new products. Its products are widely used in a variety of medical settings, from surgical centers to hospitals and even in the home.
In addition, Merit Medical Systems Inc. is well-positioned to benefit from the increasing demand for medical devices in both developed and emerging markets. Its ability to quickly adapt to changing market conditions, coupled with its strong financial performance and product quality, makes it an attractive option for both long-term and short-term investors. With a track record of dividend payments and steady growth, it is certainly worth keeping an eye on this stock for potential future gains.
Market Price
On Tuesday, the stock opened at $71.0 and closed at $69.6, down 1.4% from its prior closing price of $70.6. Analysts have been issuing reports with a favorable outlook on the company, with many expecting its stock to perform well in the near future. Their main product line consists of interventional products, specifically medical devices and systems used to diagnose and treat diseases. The company has also been performing well financially, with revenues increasing over the past few years. Their strong financial performance has resulted in an increase in their market capitalization and stock valuation.
Furthermore, they have been able to acquire several companies throughout the years, expanding their product line and presence in the market. Overall, Merit Medical Systems Inc. is a well-established business that has remained competitive despite the changing market conditions. It has gained a reputation for providing high-quality products and services, and investors are optimistic about its future prospects. Though their stock price dropped slightly on Tuesday, analysts believe this is only a temporary dip and that it will recover in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for MMSI. More…
| Total Revenues | Net Income | Net Margin |
| 1.14k | 61.73 | 6.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for MMSI. More…
| Operations | Investing | Financing |
| 132.1 | -54.67 | -86.98 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for MMSI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.63k | 543.9 | 18.91 |
Key Ratios Snapshot
Some of the financial key ratios for MMSI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 5.4% | 36.8% | 5.5% |
| FCF Margin | ROE | ROA |
| 8.0% | 4.5% | 3.0% |
VI Analysis
MERIT MEDICAL SYSTEMS is classified as a ‘gorilla’, a type of company with strong competitive advantages that lead to both stable and high revenue or earnings growth. This type of company is often attractive to investors, who are drawn to the potential for long-term gains and stability. According to the VI Star Chart, MERIT MEDICAL SYSTEMS is strong in growth and profitability, medium in asset and weak in dividend, which further supports its status as a gorilla. Additionally, the company has a high health score of 8 out of 10, reflecting its ability to manage its cash flows and debt responsibly and safely ride out any crisis without the risk of bankruptcy. Investors looking for long-term gains and stability are likely to be drawn to companies like MERIT MEDICAL SYSTEMS, which have strong fundamentals that reflect their potential for growth. With its high health score, the company is well-positioned to withstand uncertain economic conditions while continuing to grow. Furthermore, its strong competitive advantages make it an appealing choice for investors who are looking for a company that can consistently produce returns over time. More…
VI Peers
The company’s products are used in a variety of medical procedures, including cardiovascular, gastrointestinal, urological, and obstetrical/gynecological procedures. The company has a strong competitive position in the medical device market, with a leading market share in many of its product categories.
However, the company faces competition from a number of well-established competitors, including Medeon Biodesign Inc, Pixium Vision SA, and AngioDynamics Inc.
– Medeon Biodesign Inc ($TPEX:6499)
Medeon Biodesign Inc is a medical device company that develops and commercializes products for the treatment of cardiovascular diseases. The company has a market cap of 4.55B and a ROE of -6.27%. Medeon Biodesign Inc’s products are used in the treatment of coronary artery disease, heart failure, and other cardiovascular conditions. The company’s products are sold in over 30 countries worldwide.
– Pixium Vision SA ($OTCPK:PXMVF)
Pixium Vision SA is a French company that designs, develops, and markets bionic vision systems to enable patients who have lost their sight to regain some level of vision. The company’s products include the PRIMA bionic vision system, which consists of an implantable microstimulator and a wearable camera and glasses, and the IRIS II bionic vision system, which consists of an implantable microstimulator and a contact lens. Pixium Vision SA’s products are intended for use in patients with retinitis pigmentosa, macular degeneration, and other degenerative eye diseases.
– AngioDynamics Inc ($NASDAQ:ANGO)
AngioDynamics Inc is a medical device company that designs, manufactures, and sells products used by interventional physicians to treat vascular diseases. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc has a market cap of 549.46M as of 2022, a Return on Equity of -5.11%. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc’s products are sold in over 50 countries worldwide.
Summary
Merit Medical Systems Inc. (MERIT) is a leading manufacturer and marketer of disposable medical devices used in interventional, diagnostic, and therapeutic procedures. The company has seen an increase in revenue and gross profit, as well as a decrease in operating expenses in the last year. MERIT has also been able to successfully manage its debt to equity ratio. Overall, MERIT appears to be a solid long-term investment opportunity, given its strong financials and positive analyst sentiment.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
